BR112015010625B1 - Peptídeos - Google Patents

Peptídeos Download PDF

Info

Publication number
BR112015010625B1
BR112015010625B1 BR112015010625-0A BR112015010625A BR112015010625B1 BR 112015010625 B1 BR112015010625 B1 BR 112015010625B1 BR 112015010625 A BR112015010625 A BR 112015010625A BR 112015010625 B1 BR112015010625 B1 BR 112015010625B1
Authority
BR
Brazil
Prior art keywords
peptide
seq
fviii
glu
lys
Prior art date
Application number
BR112015010625-0A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112015010625A2 (pt
Inventor
David Wraith
Heather Streeter
Original Assignee
Apitope International Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1220328.7A external-priority patent/GB201220328D0/en
Priority claimed from GBGB1316660.8A external-priority patent/GB201316660D0/en
Application filed by Apitope International Nv filed Critical Apitope International Nv
Publication of BR112015010625A2 publication Critical patent/BR112015010625A2/pt
Publication of BR112015010625B1 publication Critical patent/BR112015010625B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112015010625-0A 2012-11-12 2013-11-11 Peptídeos BR112015010625B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1220328.7 2012-11-12
GBGB1220328.7A GB201220328D0 (en) 2012-11-12 2012-11-12 Peptides
GB1316660.8 2013-09-19
GBGB1316660.8A GB201316660D0 (en) 2013-09-19 2013-09-19 Peptides
PCT/IB2013/060060 WO2014072958A1 (en) 2012-11-12 2013-11-11 Peptides

Publications (2)

Publication Number Publication Date
BR112015010625A2 BR112015010625A2 (pt) 2017-08-22
BR112015010625B1 true BR112015010625B1 (pt) 2023-03-07

Family

ID=49627013

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015010625-0A BR112015010625B1 (pt) 2012-11-12 2013-11-11 Peptídeos

Country Status (28)

Country Link
US (2) US20150306192A1 (enExample)
EP (1) EP2917232B1 (enExample)
JP (1) JP6247696B2 (enExample)
KR (1) KR102165486B1 (enExample)
CN (1) CN104903347B (enExample)
AU (1) AU2013343024B2 (enExample)
BR (1) BR112015010625B1 (enExample)
CA (1) CA2890835C (enExample)
CY (1) CY1119164T1 (enExample)
DK (1) DK2917232T3 (enExample)
EA (1) EA036483B1 (enExample)
ES (1) ES2626881T3 (enExample)
HR (1) HRP20170794T1 (enExample)
HU (1) HUE033586T2 (enExample)
IL (1) IL238627B (enExample)
IN (1) IN2015DN03814A (enExample)
LT (1) LT2917232T (enExample)
MX (1) MX350777B (enExample)
MY (1) MY176708A (enExample)
NZ (1) NZ708812A (enExample)
PH (1) PH12015501033B1 (enExample)
PL (1) PL2917232T3 (enExample)
PT (1) PT2917232T (enExample)
RS (1) RS56069B1 (enExample)
SG (1) SG11201503657UA (enExample)
SI (1) SI2917232T1 (enExample)
WO (1) WO2014072958A1 (enExample)
ZA (1) ZA201503127B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018127830A1 (en) 2017-01-04 2018-07-12 Apitope International Nv S-arrestin peptides and therapeutic uses thereof
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
EP3715374A1 (en) 2019-03-23 2020-09-30 Ablevia biotech GmbH Compound for the sequestration of undesirable antibodies in a patient
GB201909774D0 (en) * 2019-07-08 2019-08-21 Apitope Tech Bristol Limited Method
WO2022063887A1 (en) 2020-09-23 2022-03-31 Ablevia Biotech Gmbh Compound for increasing the efficacy of factor viii replacement therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1918298T3 (da) 2000-08-21 2010-11-29 Apitope Technology Bristol Ltd Peptid
WO2002060917A2 (en) * 2000-12-01 2002-08-08 Regents Of The University Of Minnesota Method to treat hemophilia
FR2842812A1 (fr) * 2002-07-26 2004-01-30 Pf Medicament Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse
JP2006188507A (ja) * 2004-12-10 2006-07-20 Tokyo Univ Of Agriculture & Technology 蛋白質の溶解度向上方法
ES2386462T3 (es) * 2005-10-28 2012-08-21 Boehringer Ingelheim International Gmbh Ensayo de la actividad NS2/3 del virus de la hepatitis C
GB0723712D0 (en) * 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
CA2780763A1 (en) * 2009-11-13 2011-05-19 Puget Sound Blood Center Factor viii b cell epitope variants having reduced immunogenicity
US8969524B2 (en) * 2010-10-27 2015-03-03 Baxter International Inc. FVIII peptides for immune tolerance induction and immunodiagnostics

Also Published As

Publication number Publication date
BR112015010625A2 (pt) 2017-08-22
HUE033586T2 (hu) 2017-12-28
US20150306192A1 (en) 2015-10-29
PH12015501033A1 (en) 2015-07-27
AU2013343024B2 (en) 2017-06-01
SG11201503657UA (en) 2015-06-29
DK2917232T3 (en) 2017-06-12
CA2890835C (en) 2021-11-23
IN2015DN03814A (enExample) 2015-10-02
HRP20170794T1 (hr) 2017-08-11
NZ708812A (en) 2019-03-29
RS56069B1 (sr) 2017-10-31
KR20150084852A (ko) 2015-07-22
PT2917232T (pt) 2017-06-09
PL2917232T3 (pl) 2017-09-29
AU2013343024A1 (en) 2015-05-21
US20210346476A1 (en) 2021-11-11
SI2917232T1 (sl) 2017-07-31
PH12015501033B1 (en) 2015-07-27
EA201590927A1 (ru) 2015-10-30
EP2917232B1 (en) 2017-03-01
ZA201503127B (en) 2016-10-26
CA2890835A1 (en) 2014-05-15
EA036483B1 (ru) 2020-11-16
CN104903347A (zh) 2015-09-09
LT2917232T (lt) 2017-06-26
EP2917232A1 (en) 2015-09-16
WO2014072958A8 (en) 2016-10-13
MY176708A (en) 2020-08-19
ES2626881T3 (es) 2017-07-26
HK1209138A1 (en) 2016-03-24
WO2014072958A1 (en) 2014-05-15
IL238627B (en) 2018-12-31
JP6247696B2 (ja) 2017-12-13
IL238627A0 (en) 2015-06-30
MX350777B (es) 2017-09-15
CY1119164T1 (el) 2018-02-14
KR102165486B1 (ko) 2020-10-15
CN104903347B (zh) 2020-02-21
MX2015005973A (es) 2015-09-16
JP2016501182A (ja) 2016-01-18

Similar Documents

Publication Publication Date Title
ES2458315T7 (es) Péptidos de FVIII y su uso en la inducción de tolerancia en pacientes hemofílicos
US20210346476A1 (en) Modified FVIII Apitope Peptides
ES2525448T3 (es) Péptidos derivados de FVIII y su uso en la inducción de tolerancia en pacientes hemofílicos
HK1209138B (en) Factor viii-derived peptides for use in the treatment of haemophilia a
HK1144292B (en) Fviii peptides and their use in tolerising haemophiliacs
HK1172240B (en) Fviii-derived peptides and their use in tolerising haemophiliacs
HK1172240A (en) Fviii-derived peptides and their use in tolerising haemophiliacs
HK1173358B (en) Fviii-derived peptides

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/11/2013, OBSERVADAS AS CONDICOES LEGAIS

B25A Requested transfer of rights approved

Owner name: WORG PHARMACEUTICALS (ZHEJIANG) CO., LTD. (CN)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2853 DE 09-09-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.